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The major histocompatibility complex (MHC) class-I restricted epitope of Hantaan virus nucleocapsid protein (N) was identified using
overlapping peptides and BALB/c mice. Using the MHC tetramer derived from the epitope, we found that the level of N-specific CD8+ T cells
increased to approximately 20% of all antigen-specific CD8+ T cells in a mouse model of transient infection. However, N-specific CD8+ T cells
were undetectable in a mouse model of persistent infection, both in the persistently infected phase and in the convalescent phase. Levels of CD8+
T cells producing interferon-γ were weak in both the acute and convalescent phases in the persistently infected model. These results indicate that
hantavirus strongly suppresses the production of N-specific CD8+ T cells throughout the course of infection in persistently infected mice.
Moreover, N-specific CD8+ T cells were not effective in recovering persistently infected mice, despite the existence of abundant N antigen in vivo.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hantavirus; MHC tetramer; Hantavirus-specific CD8+ T cell; Persistent infectionIntroduction
Hantaviruses comprise the genus Hantavirus in the family
Bunyaviridae. Hantaviruses are spherical, enveloped viruses, with
a diameter of 80–120 nm. The hantavirus genome consists of three
segments of single-stranded, negative-sense RNA. The three
segments have been designated the large (L), medium (M), and
small (S) segments, based on their size. The L segment encodes an
RNA-dependent RNA polymerase; the M segment encodes the
surface glycoprotein precursor, which is cotranslationally cleaved
into two glycoprotein spikes (Gn and Gc); and the S segment
encodes the nucleocapsid protein (N) (Lednicky, 2003).
To date, 22 virus species have been classified in the genus
Hantavirus based on antigenic, genetic, and ecological character-
istics. Rodents are the natural reservoirs of all but one species, the
Thottapalayan virus, whose reservoir animal is the insectivore
Suncus murinus (Carey et al., 1971). Because they are species-⁎ Corresponding author. Fax: +81 11 706 7879.
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doi:10.1016/j.virol.2007.02.039specific, it is generally believed that hantaviruses have coevolved
with their hosts, and nearly identical phylogenetic trees can be
constructed from host mitochondrial DNA sequences and viral
RNA sequences (Meyer and Schmaljohn, 2000). Hantaviruses
cause two serious and often fatal human diseases, hemorrhagic
fever with renal syndrome (HFRS) and hantavirus pulmonary
syndrome (HPS). Transmission of hantaviruses to humans does
not require direct human-rodent contact. Instead, humans typically
become infected by inhaling virus-contaminated aerosols of rodent
excreta, such as feces, saliva, or urine (Lee and van der Groen,
1989).
Because hantaviruses have no, or an incomplete, cytopathic
effect on cultured cells (Ogino et al., 2004) and are generally
non-lytic (Pensiero et al., 1992; Yanagihara and Silverman,
1990; Zaki et al., 1995), the pathogenesis of HFRS and HPS
may be related to immune-mediated effector responses of the
host itself. Indeed, several studies have suggested that
hantavirus infection can induce a vigorous cellular immune
response in humans (Chen and Yang, 1990; Huang et al., 1994;
Kilpatrick et al., 2004; Mustonen et al., 1994; Nolte et al., 1995;
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important to discern host immune responses to the virus,
particularly hantavirus-specific CD8+ cytotoxic T lymphocytes
(CTLs). The interaction of hantavirus-specific CTLs with the
hantavirus remains unclear. In contrast to humans, the reservoir
animals are persistently infected without signs of disease
(Meyer and Schmaljohn, 2000).
In a previous study, we established a persistent infection
model by inoculating mice with a sublethal dose of Hantaan
virus (HTNV), the prototype of the genus Hantavirus, within
24 h of birth. The number of interferon (IFN)-γ-inducible
HTNV-specific CD8+ T cells first increased in the acute phase
and then decreased to an undetectable level soon thereafter.
Viral antigen was detected in the lung until 90 days after the
infection, although no HTNV-specific CD8+ T cells were
observed at that time; T cells reappeared at 120 days, although
no detectable viral antigen was present in the lung (Araki et al.,
2003). A similar suppression and reappearance of HTNV-
specific CD8+ T cells was observed using a severe combined
immune deficiency (SCID) mouse model in which spleen cells
from immunocompetent BALB/c mice were passively trans-
ferred to SCID mice 14 days after infection (Araki et al., 2004a).
These results indicated that disseminated HTNV infection
before the induction of an immune response is important for the
establishment of persistent infection and the suppression of
HTNV-specific CD8+ T cells in mice. HTNV-specific CD8+ T
cells were induced in HTNV-infected nude mice after adoptive
transfer of spleen cells from immunocompetent BALB/c mice
(Araki et al., 2004a), indicating that the HTNV-specific CD8+ T
cells appearing in SCID or nude mice were produced by the
transferred cells. This suggests that the peripheral CD8+ T cell
response is more important than the thymus in suppressing
specific T cell responses in persistently infected mice.
Although several N-specific CTL epitopes have been deter-
mined in C57BL/6mice, as yet, none has been reported in BALB/c
mice (Park et al., 2000; Maeda et al., 2004, 2005). To further
analyze the CD8+ T cell response, we first identified the
immunodominant CTL epitope in the HTNV nucleocapsid protein
(N), an abundant antigen of hantaviruses, in BALB/c mice. We
then established an epitope-specific MHC tetramer assay and
sequentially analyzed the epitope-specific CD8+ Tcell response by
comparing the transient infection model and the persistent
infection model.
Results
Screening for the N-specific CD8+ T cell epitope in BALB/c mice
We used HTNV-infected P388D1 cells (H-2d) as antigen-
presenting cells to detect all antigen-specific CD8+ T cells.
Accordingly, we used BALB/c mice (H-2d) for screening. In total,
105 15-mer peptides with 10 amino acid overlaps, encompassing
the entire HTNV N protein, were divided into seven pools (Table
1). The peptide mixtures from each pool were screened for their
capacity to stimulate IFN-γ production in spleen cells from
BALB/c mice infected with HTNV. Based on the FACS analysis,
the peptide mixture from pool 6 was able to induce IFN-γ (Fig.1A). Approximately 20% of all antigen-specific CD8+ T cells
were raised as N-specific cells (Fig. 1A). Next, we examined the
peptides in pool 6 (nos. 81–94) individually, and determined that
peptides 83 and 84 were positive for IFN-γ induction (Fig. 1B).
To identify the minimum sequence of the T cell epitope, we
examined seven additional 11-mer peptides, encompassing the
sequence represented in peptides 83 and 84. As shown in Fig. 1C,
peptides 108 and 109 stimulated HTNV-specific CD8+ T cells,
while peptides 106, 107, and 110 did not. Because a 9-mer
peptide is recommended for synthesis of MHC class I tetramers,
we examined the shorter sequence ILQDMRNTI (N335–343),
which was suggested from the results with peptides 108 and 109.
As shown in Fig. 1D, this peptide induced IFN-γ (0.14%), and
we thus deemed it the sole epitope for N-specific CD8+ T cells in
BALB/c mice (H-2d).
Determination of MHC restriction in sequence NP335–343
To determine the MHC restriction of the HTNV-specific
response to this peptide derived from N, an inhibition-of-
peptide-stimulation assay was conducted using antibodies
specific to the class I molecules Dd or Kd. The percentage of
peptide-specific CD8+ T cells was 0.04% with the anti-H-2Dd
antibody and 0.01% with the anti-H-2Kd antibody (Fig. 2).
Although the percentage of positive cells was lower than
measured in the same experiment in Fig. 1, the peptide
stimulation was only blocked by the antibody to H-2Kd,
indicating that the epitope was H-2Kd-restricted. The
percentage of positive cells varied depending on the condition
of the cells. We obtained reproducible results from several
independent experiments; therefore, we deemed this to be of
significance. In addition, we also confirmed H-2Kd binding
affinity using the Bioinformatics and Molecular Analysis
Section (BIMAS) algorithms (available at http://thr.cit.nih.
gov/molbio/hla_bind/) (Parker et al., 1994). The sequence of
the N335–343 peptide scored the highest in H-2Kd (69.12),
but lowest in H-2Dd (0.54) and H-2Ld (1.5). The specific
motif for peptides that bind H-2Kd is believed to be a
nonamer, with tyrosine or phenylalanine residues in the
second amino acid position, and leucine or isoleucine in the
carboxyl-terminal or ninth amino acid position as dominant
anchoring positions. Although the sequence that we identified
does not have an aromatic residue in the second position, it is
similar to that of the HIV-1 gag epitope (AMQMLKETI),
which also does not contain an anchoring aromatic residue in
position two (Mata et al., 1998). These results also suggest
that the N335–343 peptide is H-2Kd-restricted. Thus, a
tetramer was prepared that consisted of H-2Kd molecules
loaded with the N335–343 peptide; it was named NP335–343.
Response of NP335–343-specific CD8+ T cells in a transient
infection model
To evaluate the effect of NP335–343 staining on epitope-
specific CD8+ T cells, we first stained spleen cells from the
transient infection mouse model. The frequency of NP335–
343-positive cells, as a percentage of total CD44+ CD8+ T
Table 1
Peptide library derived from the full-length N protein: overlapping peptides used to test IFN-γ-inducing ability
Peptide AA position Sequence Peptide AA position Sequence Peptide AA position Sequence Peptide AA position Sequence
Pool 1 Pool 2 Pool 3 Pool 4
1 1–15 MMATMEELQREINAH 17 65–79 QLADRIATGKNLGKE 33 129–143 SFVVPILLKALYMLT 49 193–207 EITPGRYRTAVCGLY
2 5–19 MEELQREINAHEGQL 18 69–83 RIATGKNLGKEQDPT 34 133–147 PILLKALYMLTTRGR 50 197–211 GRYRTAVCGLYPAQI
3 9–23 QREINAHEGQLVIAR 19 73–87 GKNLGKEQDPTGVEP 35 137–151 KALYMLTTRGRQTTK 51 201–215 TAVCGLYPAQIKARQ
4 13–27 NAHEGQLVIARQKVR 20 77–91 GKEQDPTGVEPGDHL 36 141–155 MLTTRGRQTTKDNKG 52 205–219 GLYPAQIKARQMISP
5 17–31 GQLVIARQKVRDAEK 21 81–95 DPTGVEPGDHLKERS 37 145–159 RGRQTTKDNKGTRIR 53 209–223 AQIKARQMISPVMSV
6 21–35 IARQKVRDAEKQYEK 22 85–99 VEPGDHLKERSMLSY 38 149–163 TTKDNKGTRIRFKDD 54 213–227 ARQMISPVMSVIGFL
7 25–39 KVRDAEKQYEKDPDE 23 89–103 DHLKERSMLSYGNVL 39 153–167 NKGTRIRFKDDSSFE 55 217–231 ISPVMSVIGFLALAK
8 29–43 AEKQYEKDPDELNKR 24 93–107 ERSMLSYGNVLDLNH 40 157–171 RIRFKDDSSFEDVNG 56 221–235 MSVIGFLALAKDWSD
9 33–47 YEKDPDELNKRTLTD 25 97–111 LSYGNVLDLNHLDID 41 161–175 KDDSSFEDVNGIRKP 57 225–239 GFLALAKDWSDRIEQ
10 37–51 PDELNKRTLTDREGV 26 101–115 NVLDLNHLDIDEPTG 42 165–179 SFEDVNGIRKPKHLY 58 229–243 LAKDWSDRIEQWLIE
11 41–55 NKRTLTDREGVAVSI 27 105–119 LNHLDIDEPTGQTAD 43 169–183 VNGIRKPKHLYVSLP 59 233–247 WSDRIEQWLIEPCKL
12 45–59 LTDREGVAVSIQAKI 28 109–123 DIDEPTGQTADWLSI 44 173–187 RKPKHLYVSLPNAQS 60 237–251 IEQWLIEPCKLLPDT
13 49–63 EGVAVSIQAKIDELK 29 113–127 PTGQTADWLSIIVYL 45 177–191 HLYVSLPNAQSSMKA 61 241–255 LIEPCKLLPDTAAVS
14 53–67 VSIQAKIDELKRQLA 30 117–131 TADWLSIIVYLTSFV 46 181–195 SLPNAQSSMKAEEIT 62 245–259 CKLLPDTAAVSLLGG
15 57–71 AKIDELKRQLADRIA 31 121–135 LSIIVYLTSFVVPIL 47 185–199 AQSSMKAEEITPGRY 63 249–263 PDTAAVSLLGGPATN
16 61–75 ELKRQLADRIATGKN 32 125–139 VYLTSFVVPILLKAL 48 189–203 MKAEEITPGRYRTAV 64 253–267 AVSLLGGPATNRDYL
Pool 5 Pool 6 Pool 7
65 257–271 LGGPATNRDYLRQRQ 81 321–335 LFIAGIAELGAFFSI 95 377–391 LGQRIIVLFMVAWGK
66 261–275 ATNRDYLRQRQVALG 82 325–339 GIAELGAFFSILQDM 96 381–395 IIVLFMVAWGKEAVD
67 265–279 DYLRQRQVALGNMET 83 329–343 LGAFFSILQDMRNTI 97 385–399 FMVAWGKEAVDNFHL
68 269–283 QRQVALGNMETKESK 84 333–347 FSILQDMRNTIMASK 98 389–403 WGKEAVDNFHLGDDM
69 273–287 ALGNMETKESKAIRQ 85 337–351 QDMRNTIMASKTVGT 99 393–407 AVDNFHLGDDMDPEL
70 277–291 METKESKAIRQHAEA 86 341–355 NTIMASKTVGTSEEK 100 397–411 FHLGDDMDPELRTLA
71 281–295 ESKAIRQHAEAAGCS 87 345–359 ASKTVGTSEEKLRKK 101 401–415 DDMDPELRTLAQSLI
72 285–299 IRQHAEAAGCSMIED 88 349–363 VGTSEEKLRKKSSFY 102 405–419 PELRTLAQSLIDVKV
73 289–303 AEAAGCSMIEDIESP 89 353–367 EEKLRKKSSFYQSYL 103 409–423 TLAQSLIDVKVKEIS
74 293–307 GCSMIEDIESPSSIW 90 357–371 RKKSSFYQSYLRRTQ 104 413–427 SLIDVKVKEISNQEP
75 297–311 IEDIESPSSIWVFAG 91 361–375 SFYQSYLRRTQSMGI 105 416–430 DVKVKEISNQEPLKL
76 301–315 ESPSSIWVFAGAPDR 92 365–379 SYLRRTQSMGIQLGQ
77 305–319 SIWVFAGAPDRCPPT 93 369–383 RTQSMGIQLGQRIIV
78 309–323 FAGAPDRCPPTCLFI 94 373–387 MGIQLGQRIIVLFMV
79 313–327 PDRCPPTCLFIAGIA
80 317–331 PPTCLFIAGIAELGA
The amino acid position indicates the location of the indicated sequences in the N protein.
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Fig. 1. Peptide screening for the N protein epitope from infected adult mice. Spleen cells were obtained from HTNV-infected BALB/c mice 10 days after HTNV inoculation.
Spleen cells were cultured in the presence of brefeldin A and IL-2. IFN-γ+ CD8+ cells were detected using flow cytometry. The numbers are the percentages of IFN-γ+ CD8+
cells. (A) Spleen cells were cultured with HTNV-infected P388D1 cells (positive control) or with peptide pools (Table 1). IFN-γ positive cells were detected only with pool 6
peptides. (B) Spleen cells were cultured with peptides 81–94 from pool 6. IFN-γ-positive cells were detected using peptides 83 and 84. (C) Spleen cells were cultured with or
without peptides 106–110 derived from peptides 83 and 84. IFN-γ-positive cells were detected using peptides 108 and 109. (D) Spleen cells were cultured with peptide 93
(negative control) or NP335–343 derived from peptides 110 and 112. The NP335–343 peptide stimulated CD8+ cells to produce IFN-γ.
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after infection (1.11%); it then decreased at 3 weeks after
infection and continued at a low level thereafter (Figs. 3A, B).
The same kinetic profile was produced by NP335–343
peptide-specific, IFN-γ-inducible CD8+ T cells 3, 7, 12, and
14 days post infection (data not shown). Furthermore, these
kinetics were similar to those of virus-specific, IFN-γ-
inducible CD8+ T cells (Fig. 3C). NP335–343-specific CD8+
T cells comprised approximately 20% of all antigen-specific
CD8+ T cells (Figs. 3B, C). This is in good correspondence to
previous data (Fig. 1A). These data indicated that the transient
infection model had a normal immune response and that the
tetramer NP335–343 could detect epitope-specific CD8+ T
cells.
Response of NP335–343-specific CD8+ T cells in a persistent
infection model
Next, we examined the kinetics involved in NP335–343
staining of epitope-specific CD44+ CD8+ T cells in a persistent
infection mouse model. As a result, a very low level of NP335–
343-specific CD8+ T cell response was observed at all time points.
NP335–343-specific CD8+ T cells tended to appear just before
viral antigen elimination (13 weeks after infection [0.31%]; Fig.
4A). The total number of NP335–343-positive CD44+ CD8+ T
cells was equal to or lower than the lowest level in the transient
infection model (Figs. 3C and 4C). The same tendency was seen inthe NP335–343 peptide stimulation assays performed at 2, 5, 8,
10, 13, and 17 weeks (data not shown).
In our previous study with this model, we found that the
IFN-γ-producing CD8+ T cell response appeared in the acute
phase, and was then quickly suppressed in the following viral
persistent phase. IFN-γ-producing CD8+ T cells reappeared at
about 17 weeks after infection, when the persistent infection
ended (Araki et al., 2003). We examined the kinetics of the
IFN-γ-producing CD8+ T cells in more detail and confirmed
that the IFN-γ-producing cell response was very weak
compared to that in the transient infection model. It appeared
twice, at 2 weeks after infection and just before viral antigen
elimination (Fig. 4C). We found suppression of IFN-γ-
production and also suppression of NP335–343-specific
CD8+ T cell production. We looked for, but did not detect,
other N-specific CD8+ T cell epitopes in this model (data not
shown). These results indicate that hantavirus strongly
suppresses the production of N-specific CD8+ T cells in the
persistent infection model (Fig. 5).
Discussion
We identified an N-specific CD8+ T cell epitope in BALB/c
mice (H-2d). Specifically, we found one major epitope in
BALB/c mice corresponding to amino acids 335–343 of the
HTNV N protein, which was H-2Kd-restricted. At least three
epitopes have been found within HTNVN in C57BL/6 mice (H-
Fig. 2. The NP335–343 peptide is MHC class I H-2Kd-restricted. Spleen cells
were obtained from HTNV-infected BALB/c mice 10 days after HTNV
inoculation. Spleen cells were cultured in the presence of brefeldin A and IL-2.
When required, anti-H-2Dd or H-2Kd antibodies were added simultaneously
with or without the NP335–343 peptide. IFN-γ+ CD8+ cells were detected using
flow cytometry. The numbers are the percentages of IFN-γ+ CD8+ cells.
296 M. Taruishi et al. / Virology 365 (2007) 292–3012b) by the BIMAS prediction algorithm (Park et al., 2000). The
previously identified epitopes NP3 (amino acids 221–228:
SVIGFLAL), NP4 (amino acids 328–335: LGAFFSIL), and
NP7 (amino acids 422–429: SNQEPLKL) were different from
our identified epitope, but NP4 does partially overlap with it.
For Sin Nombre virus (SNV) infection, peptide screening in B6.
PL Thy1a/Cy mice (H-2b) identified four epitopes, NC94–101
(SSLRYGNV), NC175–189 (minimal epitope:SMPTAQSTM),
NC211–225, 217–231 (minimal epitope:SPVMGVIGF or
PVMGVIGFS), and NC331–345 (minimal epitope: FAILQ-
DMRNT or AILQDMRNTI) (Maeda et al., 2004, 2005). The
NC331–345 epitope is the same as the HTNV CD8+ T cell
epitope (ILQDMRNTI) identified in BALB/c mice. This se-
quence has also been shown to elicit a strong CTL response in
humans (HLA-A2.1) who have been infected with HTNV and
recovered (Lee et al., 2002). In addition, this region is highly
conserved in all hantavirus prototypes, suggesting that this
universal region may be important in eliciting hantavirus-
specific T-cell responses.
In Puumala virus (PUUV) infection, N protein may be the
dominant target of CD8+ CTLs in infected patients (Van Epps et
al., 2002). In immunization experiments using recombinant
vaccinia viruses in a mouse model, both SNV N protein and
especially HTNV N protein induced IFN-γ-producing cells
(Maeda et al., 2004). Therefore, N seems to be a major CTL
epitope. However, approximately 20% of all antigen-specific
CD8+ T cells were N-specific in our study (Fig. 1A), indicating
that N is not the major epitope in BALB/c mice. Gn and Gc maybe major target proteins of CD8+ T cells in this mouse strain.
Indeed, there are several reports of antigen-specific CD8+ T
cells being elicited not only by N, but also by Gn and Gc in
patients with PUUV, SNV, and HTNV (Van Epps et al., 1999;
Kilpatrick et al., 2004; Terajima et al., 2002).
The frequency of antigen-specific CD8+ T cells may be
related to pathogenic severity. In SNV infection, the frequency
of SNV-specific CD8+ T cells was significantly higher in
patients with severe HPS (7.4–44.2%) than in patients with
moderate HPS (2.9–9.8%) (Kilpatrick et al., 2004). Thus, virus-
specific CD8+ T cells may contribute to disease outcome. In the
BALB/c mice used in this study, the total HTNV-specific CD8+
T cell response itself is very low (less than 2%) compared to the
response to other viruses (e.g., above 20% in lymphocytic
choriomeningitis virus; Fig. 1) (Woo et al., 2005; Zhou et al.,
2004). The low frequency of HTNV-specific CD8+ T cells in
mice seems to be related to asymptomatic infection.
We synthesized the HTNV-specific MHC tetramer NP335–
343, derived from the HTNV epitope identified in BALB/c mice,
to analyze epitope-specific CD8+ T cells. Using this tetramer, we
observed that epitope-specific CD8+ T cells appeared soon after
infection (day 7) in a transient infection model. This corresponded
to the kinetics of IFN-γ-inducible CD8+ T cells. These results
suggest that the tetramer NP335–343 is a useful tool to analyze
epitope-specific CD8+ T cells and that the immune response is
normal in the transient infection model. However, a low induction
of N-specific CD8+ Tcells was observed in the persistent infection
model. Although one peak in the appearance of NP335–343-
specific CD8+ Tcells occurred just before viral antigen elimination
(13 weeks), the level was quite low, even in the convalescent
phase. Mice are also killed by HTNV infection when inoculated
with HTNV on day 0 (Ebihara et al., 2000; Yoshimatsu et al.,
1997). Persistent hantavirus infection in mice occurs only when
they are inoculated with HTNV within 24 h of birth (Araki et al.,
2004b). Viruses can readily proliferate in newborn mice because
the immune response may be incomplete compared to adult mice.
When spleen cells from immunocompetent BALB/c mice were
passively transferred to SCID mice 14 days after infection, they
permitted viral persistence and suppression of virus-specific CD8+
T cells. However, when spleen cells from immunocompetent
BALB/c mice were passively transferred to SCID mice on the day
of infection, they expressed virus-specific CD8+ T cells normally
(Araki et al., 2004a). These results suggest that CTL production is
dependent on the host environment and is regulated by the viral
antigen. It is thought that suppression of epitope-specific CD8+ T
cell production in this persistent infection model is also caused by
large amounts of viral antigen.
CTLs are an important host–defense mechanism against
many viral infections, particularly for the clearance of virus-
infected cells. N-specific CTLs are strongly regulated and
suppressed in this persistently infected mouse model by an
unknown mechanism. Both pathogenic and nonpathogenic
hantaviruses infect primary human endothelial cells (Pensiero et
al., 1992; Yanagihara and Silverman, 1990) and dendritic cells
(Raftery et al., 2002), as well as other cell lines from many
species. Although there are no reports to show the infected cells
in vivo in mice, infected immune cells are thought to regulate
Fig. 3. Sequential analysis of NP335–343-specific CD8+ T cells in a transient infection model. Spleen cells from normal adult mice and transiently infected adult
mice, which were inoculated with HTNV cl-1, were stained with NP335–343. The number of CD8+ T cells specific to the CTL epitope NP335–343 was
determined by staining splenocytes with anti-CD8, anti-CD44, and MHC-I tetramer. (A) The dot plots are gated on total CD8+ T cells, and the numbers are the
percentages of tetramer-binding CD8+ T cells of total CD8+ T cells. (B) The representative percentage of CD8+ T cells positive for NP335–343 is plotted over time
following infection. The dotted line indicates the level of detection based on tetramer staining of splenocytes from naïve mice. (C) Spleen cells from BALB/c mice
with or without HTNV infection were incubated with HTNV-infected P388D1 cells for 6 h in the presence of brefeldin A and IL-2. The representative percentage e
of CD8+ T cells producing IFN-γ is plotted over time following infection. The dotted line indicates the level of detection based on IFN-γ staining of splenocytes
from naïve mice.
297M. Taruishi et al. / Virology 365 (2007) 292–301the alteration of these CTLs. We suspect that the alteration is
triggered about 2 weeks after infection, as we have found that
cells that strongly express N are detected only in the spleen of
the model mice after 2 weeks of infection (unpublished data).
Viral antigen is first detected in the spleen after infection
(Yoshimatsu et al., 1997), and the change in CTLs occurs during
this early phase. These infected cells may be immune cells, and
we speculate that after infection they are involved in regulating
immune responses, including the CTL response, and trigger
persistent infection or viral pathogenesis. In conclusion, we
demonstrated that major epitope-specific CD8+ T cell produc-
tion is strongly suppressed in a persistently infected mouse
model. These two mouse models of transient and persistent
infection are very useful for analyzing the immune response of
virus-specific CD8+ T cells with MHC tetramers. Using thismethod, further analyses should be performed to examine other
protein-specific CD8+ T cells, especially Gn and Gc. Although
the molecular mechanism of this suppression requires further
investigation, the strong suppression of the epitope-specific
CD8+ T cells in mice may be related to the induction of an
asymptomatic infection. In particular, our findings may help
improve therapies for patients with severe diseases controlled
by CD8+ T cells.
Materials and methods
Mice
All mice were treated according to the laboratory animal
control guidelines of our institute, which conform to those of the
Fig. 4. Sequential analysis of NP335–343-specific CD8+ T cells in a persistent infection model. BALB/c mice were inoculated with HTNV after birth (<24 h)
and killed after several weeks. “Infected” indicates adult BALB/c mice that were inoculated with HTNV and recovered (positive controls). “Uninfected”
denotes normal BALB/c mice (negative controls). (A) The dot plots are gated on total CD8+ T cells, and the numbers are the percentages of tetramer-binding
CD8+ T cells of total CD8+ T cells. (B) The representative percentage of CD8+ T cells positive for NP335–343 is plotted over time following infection. The
dotted line indicates the level of detection based on tetramer staining of splenocytes from naïve mice. (C) Spleen cells from BALB/c mice with or without
HTNV infection were incubated with HTNV-infected P388D1 cells for 6 h in the presence of brefeldin A and IL-2. The representative percentage of CD8+ T
cells producing IFN-γ is plotted over time following infection. The dotted line indicates the level of detection based on IFN-γ staining of splenocytes from
naïve mice.
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week-old female BALB/c mice were obtained from SLC
(Hamamatsu, Japan). All experiments were performed in a
class P3 facility.
Virus and viral infection of mice
HTNV cl-1 was obtained by plaque cloning from the HTNV
strain 76–118 (Ebihara et al., 2000). The virus was propagated
in the E6 clone of the Vero cell line (ATCC c1008) in Eagle's
minimal essential medium (EMEM; Invitrogen, Carlsbad, CA),
supplemented with 5% fetal bovine serum (FBS). We used two
series of infected mice. For the production of persistently
infected mice, BALB/c mice were subcutaneously (s.c.)
inoculated with 1.3 focus-forming units (FFU) of HTNV within
24 h of birth (1.3 FFU=0.1 NMLD50 [50% newborn mouselethal dose]). For the production of transiently infected mice,
adult (more than 5 weeks old) mice were intraperitonially
inoculated with 160,000 FFU of HTNV.
Cells
The murine macrophage-like cell line P388D1 (H-2d) was
cultured in RPMI 1640 medium (Sigma, St. Louis, MO),
supplemented with 5% FBS and 2-mercaptoethanol (2-ME,
50 μM). P388D1 cells continuously infected with HTNV
were prepared as antigen-presenting cells, as described
previously (Araki et al., 2003). Single-cell suspensions of
spleen cells were obtained by homogenizing spleens in RPMI
1640 medium, supplemented with 10% FBS and 2-ME
(50 μM). Erythrocytes were lysed with ACT solution (0.83%
NH4Cl).
Fig. 5. Schema showing fluctuations in the numbers of CD8+ T cells producing IFN-γ or that are positive for NP335–343, neutralizing antibodies titers, and antigen
loads (amounts of N protein in lungs) in HTNV-infected adult or newborn mice based on data from the literature (Araki et al., 2003). (A) In transiently infected mice,
NP335–343-positive CD8+ T cells were normally expressed soon after infection, suggesting that transiently infected mice have normal immune responses. (B) In
persistently infected mice, IFN-γ-producing virus-specific CD8+ T cells were induced in the acute and convalescent phases. However, typical NP335–343-positive
CD8+ T cells were not detected at all time points. These results suggest that NP335–343-positive CD8+ T cells were suppressed by a viral antigen.
299M. Taruishi et al. / Virology 365 (2007) 292–301Peptides and other reagents
Overlapping 15-mer peptides (n=105) with 10-amino acid
overlaps, spanning residues 1–430 of the HTNV nucleocapsid
protein (N), based on strain 76–118, and seven overlapping
11-mer peptides with 9-amino acid overlaps, spanning residues
329–347 of N, were purchased from Mimotope (Melbourne,
Australia) and Hokkaido System Science (Sapporo, Japan).
The nonamer peptide ILQDMRNTI, which was identified as
the sequence of a CTL epitope, was purchased as a highly
purified product from Hokkaido System Science. Stock
solutions of these synthetic peptides were prepared in 100%
DMSO at concentrations of 2 mg/mL for the 15-mer and 11-
mer peptides and 5 mg/mL for the nonamer peptide. All were
diluted to 0.2 μg/mL before use for in vitro stimulation. Goat
anti-mouse H-2Dd antibody (34-2-12) and goat anti-mouse H-
2Kd antibody (SF1-1.1) were purchased from BD Biosciences
(Franklin Lakes, NJ) and were used for the inhibition-of-
peptide-stimulation assay. The H-2Kd-restricted class-I peptide
tetramer from the sequence ILQDMRNTI named NP335–343
was synthesized at the NIH Tetramer Facility.
IFN-γ staining for peptide screening
To detect intracellular gamma interferon (IFN-γ), spleen
cells were added to 96-well V-bottomed plates at a concentra-
tion of 1×106 cells/well in RPMI 1640 medium, supplemented
with 10% FBS, 2-ME (50 μM), murine recombinant inter-
leukin-2 (IL-2; 40 ng/mL, Sigma), and brefeldin A (10 μg/mL,
Sigma), along with peptide or HTNV-infected or uninfected
P388D1 cells. The P388D1 cells were co-cultured at a
concentration of 5×105 cells/well with the spleen cells. Peptide
was added at a concentration of 0.1 to 0.2 μg/mL to the spleencell cultures. After a 6-h incubation, cells were suspended in
phosphate-buffered saline (PBS) and transferred to a 96-well
plate containing ethidium monoazide bromide (EMA; 5 μg/mL,
Invitrogen). After a 15-min incubation on ice in the dark, cells
were washed with PBS twice and exposed to light for 10 min.
Cells were washed with FACS buffer (PBS containing 1%
bovine serum albumin [BSA] and 0.1% NaN3) and stained with
the anti-CD8a PE (Ly-2) antibody (eBioscience, San Diego,
CA) for 30 min on ice. Cells were then washed with FACS
buffer and fixed with 2% paraformaldehyde–PBS. After a 20-
min incubation at room temperature, the cells were washed with
FACS buffer, resuspended in permeation buffer (PBS contain-
ing 0.5% BSA, 0.5% saponin [Sigma], 0.1% NaN3), and
incubated for 10 min at room temperature. The cells were then
stained with fluorescein isothiocyanate-conjugated rat anti-
mouse IFN-γ antibody (Caltag Laboratories, San Francisco,
CA), incubated for 30 min at room temperature, and washed
twice with permeation buffer. Cells were then given a final wash
with FACS buffer before analysis. Cells were analyzed using a
FACS Calibur (Becton Dickinson, Franklin Lakes, NJ) and data
analysis was conducted using FlowJo software (Tree Star, San
Carlos, CA).
Inhibition-of-peptide-stimulation assay
Spleen cells were added to 96-well V-bottomed plates at a
concentration of 1×106 cells/well in RPMI 1640 medium,
supplemented with 10% FBS, 2-ME (50 μM), murine
recombinant interleukin-2 (IL-2; 40 ng/mL, Sigma), and
brefeldin A (10 μg/mL, Sigma). The NP335–343 peptide was
added at a concentration of 0.2 μg/mL with or without anti-H-
2Dd or anti H-2Kd antibodies (50 μg/mL). To remove sodium
azide from the antibodies, immediately before the assay they
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(NIPPON Genetics, Tokyo). After a 6-h incubation, IFN-γ
staining was carried out using the method described above.
Tetramer staining and flow cytometry
Spleen cells in several phases were stained, as described
below. Cells (1×106 per well) were suspended in PBS and
transferred to a 96-well plate containing EMA (5 μg/mL). After
a 15-min incubation on ice in the dark, cells were washed with
PBS twice and exposed to light for 10 min. The cells were
washed with FACS buffer and stained with the anti-CD8a APC
and -CD44 FITC antibodies (eBioscience) for 30 min on ice.
After washing with FACS buffer, cells were stained with
NP335–343 at a 1:500 dilution for 30 min at room temperature.
Cells were then washed with FACS buffer and fixed with 2%
paraformaldehyde–PBS. Tetramer-positive CD44+ cells were
analyzed with gates set on EMA-negative and CD8-positive
cells. The cell samples were examined using a FACS Canto
(Becton Dickinson), and data analysis was conducted with
FACS Diva software (Becton Dickinson).
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